Logo image of SWAV

SHOCKWAVE MEDICAL INC (SWAV) Stock News

NASDAQ:SWAV - Nasdaq - US82489T1043 - Common Stock - Currency: USD

334.75  -0.08 (-0.02%)

After market: 334.8 +0.05 (+0.01%)

SWAV Latest News, Press Releases and Analysis

News Image
3 months ago - Sonder Capital

Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner

/PRNewswire/ -- Sonder Capital, a leading healthcare venture firm focused on innovative technologies ushering in a new standard of care in medicine, announced...

News Image
7 months ago - The Motley Fool

"Rule Breaker Investing" Mailbag: Talking Stocks and Options

We also talk with Sean Milliken, managing director of The Motley Fool Foundation’s ImpactFool (IF) Fund.

News Image
8 months ago - InvestorPlace

7 Overlooked Stocks That Belong in Every Portfolio

Looking beyond the headlines creates an opportunity for investors who have the patience to seek must-own overlooked stocks.

News Image
8 months ago - Benzinga

Why Sarepta Therapeutics Stock Is Rising Today

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stock is trading higher on Thursday after it was announced the company will be added to the S&P MidCap 400.

News Image
9 months ago - Benzinga

Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M

Johnson & Johnson acquires Proteologix for $850 million, expanding its bispecific antibody portfolio for immune-mediated diseases.

News Image
9 months ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALE, PRFT, SWAV

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
9 months ago - Kuehn Law, PLLC

Kuehn Law Encourages SWAV, ALE, PRFT, and LSAK Investors to Contact Law Firm

/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law...

News Image
9 months ago - InvestorPlace

SWAV Stock Earnings: ShockWave Medical Beats EPS, Beats Revenue for Q1 2024

SWAV stock results show that ShockWave Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

News Image
9 months ago - BusinessInsider

SWAV Stock Earnings: ShockWave Medical Beats EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips ShockWave Medical (NASDAQ:SWAV) just reported results for the first quarter of ...

News Image
9 months ago - Shockwave Medical, Inc.

Shockwave Medical Reports First Quarter 2024 Financial Results

SANTA CLARA, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of...

News Image
9 months ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGBA, HIBB, SWAV

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
9 months ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLT, HRT, SWAV, MODN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
9 months ago - The Motley Fool

Johnson & Johnson Is a King of Dividend Safety

The healthcare behemoth has fortified its dividend.

News Image
10 months ago - InvestorPlace

Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024

The medical device market is growing fast, and top medical device firms can become takeover targets. Here are three medtech stocks to watch. 

News Image
10 months ago - BusinessInsider

Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The value of the “global medical device market” is expected to jum...

News Image
10 months ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ADTH, SWAV, MODN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
10 months ago - InvestorPlace

Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.

Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder.

News Image
10 months ago - MarketBeat

MarketBeat Week in Review – 4/8 - 4/12

The latest inflation readings moved stocks lower as investors reconsidered what higher-for-longer interest rates mean for corporate earnings and stock valuation

News Image
10 months ago - InvestorPlace

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024

In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.

News Image
10 months ago - InvestorPlace

All-Time High Flyers: 7 Stocks to Buy as the Market Peaks

These stocks to buy have enjoyed big rallies and the gains look likely to continue in coming months even if the market does peak.

News Image
10 months ago - InvestorPlace

Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024

These three dividend kings are among the most reliable dividend stocks, and each has at least one strong buy rating.

News Image
10 months ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, INRD

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
10 months ago - Shockwave Medical, Inc.

Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study

Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina

News Image
10 months ago - Shockwave Medical, Inc.

Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study

Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina ...